Teneligliptin and “Thorough QTc study”: thorough enough?
Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0bb67106fff4eed93e4707707127c4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e0bb67106fff4eed93e4707707127c4c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e0bb67106fff4eed93e4707707127c4c2021-12-02T05:40:19ZTeneligliptin and “Thorough QTc study”: thorough enough?1178-7007https://doaj.org/article/e0bb67106fff4eed93e4707707127c4c2019-07-01T00:00:00Zhttps://www.dovepress.com/teneligliptin-and-ldquothorough-qtc-studyrdquo-thorough-enough-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E14 recommendations for the industry was not followed.2 The recommended design to conduct such a trial was not universally followed (Table1).View the original paper by Erande and colleaguesGhosal SDove Medical PressarticleNot applicableSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 1141-1142 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Not applicable Specialties of internal medicine RC581-951 |
spellingShingle |
Not applicable Specialties of internal medicine RC581-951 Ghosal S Teneligliptin and “Thorough QTc study”: thorough enough? |
description |
Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E14 recommendations for the industry was not followed.2 The recommended design to conduct such a trial was not universally followed (Table1).View the original paper by Erande and colleagues |
format |
article |
author |
Ghosal S |
author_facet |
Ghosal S |
author_sort |
Ghosal S |
title |
Teneligliptin and “Thorough QTc study”: thorough enough? |
title_short |
Teneligliptin and “Thorough QTc study”: thorough enough? |
title_full |
Teneligliptin and “Thorough QTc study”: thorough enough? |
title_fullStr |
Teneligliptin and “Thorough QTc study”: thorough enough? |
title_full_unstemmed |
Teneligliptin and “Thorough QTc study”: thorough enough? |
title_sort |
teneligliptin and “thorough qtc study”: thorough enough? |
publisher |
Dove Medical Press |
publishDate |
2019 |
url |
https://doaj.org/article/e0bb67106fff4eed93e4707707127c4c |
work_keys_str_mv |
AT ghosals teneligliptinandldquothoroughqtcstudyrdquothoroughenough |
_version_ |
1718400326422233088 |